|
|
|
Insider
Information: |
Santini Gino |
Relationship: |
Director |
City: |
Indianapolis |
State: |
IN |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
172,151 |
|
Indirect Shares
|
3,249 |
|
|
Direct
Value |
$82,659,733 |
|
|
Indirect Value
|
$2,702,388 |
|
|
Total
Shares |
175,400 |
|
|
Total
Value |
$85,362,121 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Eli Lilly & Co |
LLY |
Sr.VP, Corp. Strategy ... |
2009-12-07 |
96,495 |
2009-12-07 |
3,249 |
Premium* |
|
AMAG Pharmaceuticals Inc |
AMAG |
Director |
2020-11-16 |
0 |
2013-05-23 |
0 |
Premium* |
|
Collegium Pharmaceutical, Inc |
COLL |
Director |
2024-05-16 |
75,656 |
|
0 |
Premium* |
|
Horizon Pharma, Inc. |
HZNP |
Director |
2023-10-06 |
0 |
2023-10-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
83 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LLY |
Eli Lilly & Co |
Sr.VP, Corp. Strategy & Policy |
|
2007-01-17 |
4 |
A |
$52.86 |
$1,058,522 |
D/D |
20,025 |
99,467 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Sr.VP, Corp. Strategy & Policy |
|
2007-02-01 |
4 |
D |
$54.12 |
$108,078 |
D/D |
(1,997) |
97,470 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Sr.VP, Corp. Strategy & Policy |
|
2007-05-31 |
5 |
GA |
$0.00 |
$0 |
I/I |
843 |
8,653 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Sr.VP, Corp. Strategy & Policy |
|
2007-05-31 |
5 |
GD |
$0.00 |
$0 |
D/D |
843 |
96,627 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Sr.VP, Corp. Strategy & Policy |
|
2007-06-04 |
5 |
GD |
$0.00 |
$0 |
D/D |
848 |
95,779 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Sr.VP, Corp. Strategy & Policy |
|
2007-06-04 |
5 |
GA |
$0.00 |
$0 |
I/I |
848 |
9,501 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Sr.VP, Corp. Strategy & Policy |
|
2007-06-05 |
5 |
GA |
$0.00 |
$0 |
I/I |
339 |
9,840 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Sr.VP, Corp. Strategy & Policy |
|
2007-06-05 |
5 |
GD |
$0.00 |
$0 |
D/D |
339 |
95,440 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Sr.VP, Corp. Strategy & Policy |
|
2007-12-11 |
5 |
GD |
$0.00 |
$0 |
D/D |
235 |
95,205 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Sr.VP, Corp. Strategy & Policy |
|
2008-01-25 |
4 |
A |
$50.74 |
$1,192,897 |
D/D |
23,510 |
118,715 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Sr.VP, Corp. Strategy & Policy |
|
2008-02-01 |
4 |
D |
$51.52 |
$324,679 |
D/D |
(6,302) |
112,413 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Sr.VP, Corp. Strategy & BD |
|
2008-02-11 |
5 |
GD |
$0.00 |
$0 |
D/D |
2,548 |
109,865 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Sr.VP, Corp. Strategy & BD |
|
2008-02-11 |
5 |
GA |
$0.00 |
$0 |
I/I |
2,548 |
12,388 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Sr.VP, Corp. Strategy & BD |
|
2008-12-15 |
5 |
GD |
$0.00 |
$0 |
D/D |
343 |
109,522 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Sr.VP, Corp. Strategy & BD |
|
2009-02-02 |
4 |
D |
$36.82 |
$270,553 |
D/D |
(7,348) |
102,174 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Sr.VP, Corp. Strategy & BD |
|
2009-05-05 |
5 |
GA |
$0.00 |
$0 |
I/I |
5,259 |
16,145 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Sr.VP, Corp. Strategy & BD |
|
2009-05-05 |
5 |
GD |
$0.00 |
$0 |
D/D |
5,259 |
96,915 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Sr.VP, Corp. Strategy & BD |
|
2009-12-07 |
5 |
GD |
$0.00 |
$0 |
D/D |
420 |
96,495 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
Director |
|
2013-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
2,300 |
5,075 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
Director |
|
2014-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
3,800 |
8,875 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
Director |
|
2015-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,322 |
10,197 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Director |
|
2016-05-06 |
4 |
OE |
$0.00 |
$0 |
I/I |
5,258 |
5,258 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Director |
|
2016-05-06 |
4 |
D |
$13.41 |
$19,015 |
I/I |
(1,418) |
3,840 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
Director |
|
2016-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
4,768 |
14,965 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Director |
|
2017-05-03 |
4 |
OE |
$0.00 |
$0 |
I/I |
13,953 |
17,793 |
0 |
- |
|
83 Records found
|
|
Page 2 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|